[go: up one dir, main page]

AR018869A1 - Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene - Google Patents

Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene

Info

Publication number
AR018869A1
AR018869A1 ARP990102848A ARP990102848A AR018869A1 AR 018869 A1 AR018869 A1 AR 018869A1 AR P990102848 A ARP990102848 A AR P990102848A AR P990102848 A ARP990102848 A AR P990102848A AR 018869 A1 AR018869 A1 AR 018869A1
Authority
AR
Argentina
Prior art keywords
compositions
medicines
preparation
case
pharmaceutical composition
Prior art date
Application number
ARP990102848A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR018869A1 publication Critical patent/AR018869A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP990102848A 1998-06-16 1999-06-15 Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene AR018869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
AR018869A1 true AR018869A1 (es) 2001-12-12

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102848A AR018869A1 (es) 1998-06-16 1999-06-15 Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene

Country Status (30)

Country Link
EP (1) EP1087764A1 (is)
JP (1) JP2002518326A (is)
KR (1) KR20010052852A (is)
CN (1) CN1301160A (is)
AP (1) AP9901582A0 (is)
AR (1) AR018869A1 (is)
AU (1) AU4054799A (is)
BG (1) BG105041A (is)
BR (1) BR9911324A (is)
CA (1) CA2335134A1 (is)
CO (1) CO5070587A1 (is)
EA (1) EA200001186A1 (is)
GT (1) GT199900087A (is)
HN (1) HN1999000097A (is)
HR (1) HRP20000859A2 (is)
HU (1) HUP0102505A3 (is)
ID (1) ID27599A (is)
IL (1) IL138630A0 (is)
IS (1) IS5691A (is)
MA (1) MA26652A1 (is)
NO (1) NO20006312L (is)
OA (1) OA11505A (is)
PA (1) PA8475901A1 (is)
PE (1) PE20000646A1 (is)
PL (1) PL344981A1 (is)
SK (1) SK18912000A3 (is)
TN (1) TNSN99124A1 (is)
TR (1) TR200003544T2 (is)
WO (1) WO1999065486A1 (is)
ZA (1) ZA993975B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
DE60124616T2 (de) 2000-05-08 2007-09-13 Pfizer Products Inc., Groton Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
JP2004507502A (ja) * 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2604943T3 (es) 2007-02-09 2017-03-10 Ocera Therapeutics, Inc. Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
PE20000646A1 (es) 2000-08-05
CO5070587A1 (es) 2001-08-28
TR200003544T2 (tr) 2001-04-20
ID27599A (id) 2001-04-12
MA26652A1 (fr) 2004-12-20
OA11505A (en) 2004-05-07
EP1087764A1 (en) 2001-04-04
GT199900087A (es) 2000-12-07
PA8475901A1 (es) 2000-05-24
TNSN99124A1 (fr) 2005-11-10
SK18912000A3 (sk) 2001-10-08
KR20010052852A (ko) 2001-06-25
NO20006312D0 (no) 2000-12-12
ZA993975B (en) 2000-12-15
PL344981A1 (en) 2001-11-19
HN1999000097A (es) 1999-11-03
HUP0102505A3 (en) 2002-12-28
CN1301160A (zh) 2001-06-27
AU4054799A (en) 2000-01-05
WO1999065486A1 (en) 1999-12-23
BG105041A (en) 2001-08-31
IS5691A (is) 2000-10-27
HRP20000859A2 (en) 2001-04-30
NO20006312L (no) 2000-12-12
EA200001186A1 (ru) 2001-06-25
BR9911324A (pt) 2001-04-03
JP2002518326A (ja) 2002-06-25
CA2335134A1 (en) 1999-12-23
AP9901582A0 (en) 1999-06-30
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
BG104668A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
AR035792A1 (es) Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
IL145429A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2755967B1 (fr) Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
PT991653E (pt) Novos compostos
PT1263730E (pt) Derivados amina para o tratamento de apoptose
NO330934B1 (no) Flytende farmasoytisk preparat samt anvendelse og fremstilling derav.
HUP0300385A2 (hu) Aszpartil-proteáz inhibitorok
PA8529501A1 (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7."
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AR018869A1 (es) Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene
ATE440838T1 (de) Pharmazeutisch aktive sulfonylaminosäurederivate
SE0101322D0 (sv) Novel compounds
AR018868A1 (es) Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche
MXPA04005552A (es) Analogos de vitamina d.
NO880406L (no) 5-(3-alkyl-5-tert-butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem og deres anvendelse.
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
DK47988A (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
WO2002034203A3 (en) Novel derivatives of phenyl 4-aminosalicylate and method of making the same
DE60301277D1 (de) Pharmazeutische zubereitung enthaltend valaciclovir

Legal Events

Date Code Title Description
FA Abandonment or withdrawal